ý
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
¨
|
Transition Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
|
|
|
Delaware
|
|
22-3240619
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1111 Marcus Avenue
Lake Success, New York
|
|
11042
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Large accelerated filer
|
ý
|
|
Accelerated filer
|
¨
|
|
|
|
|
|
Non-accelerated filer
|
¨
|
|
Smaller reporting company
|
¨
|
|
Part I - Financial Information
|
Page
|
|
|
|
|
|
|
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
|
Part II - Other Information
|
|
|
|
|
Items 3, 4 and 5 are not applicable
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
|
|
||
|
|
December 31,
|
|
June 30,
|
||||
|
2015
|
|
2015
|
||||
ASSETS
|
(Unaudited)
|
|
(Note)
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
177,100
|
|
|
$
|
166,922
|
|
Accounts receivable, less allowance for doubtful accounts of $1,188 and $896
|
350,408
|
|
|
320,197
|
|
||
Inventories
|
403,318
|
|
|
382,211
|
|
||
Deferred income taxes
|
21,027
|
|
|
20,758
|
|
||
Prepaid expenses and other current assets
|
49,513
|
|
|
42,931
|
|
||
Total current assets
|
1,001,366
|
|
|
933,019
|
|
||
Property, plant and equipment, net
|
382,830
|
|
|
344,262
|
|
||
Goodwill
|
1,219,725
|
|
|
1,136,079
|
|
||
Trademarks and other intangible assets, net
|
659,267
|
|
|
647,754
|
|
||
Investments and joint ventures
|
20,214
|
|
|
2,305
|
|
||
Other assets
|
33,458
|
|
|
33,851
|
|
||
Total assets
|
$
|
3,316,860
|
|
|
$
|
3,097,270
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
280,042
|
|
|
$
|
251,999
|
|
Accrued expenses and other current liabilities
|
89,965
|
|
|
79,167
|
|
||
Current portion of long-term debt
|
41,552
|
|
|
31,275
|
|
||
Total current liabilities
|
411,559
|
|
|
362,441
|
|
||
Long-term debt, less current portion
|
940,462
|
|
|
812,608
|
|
||
Deferred income taxes
|
145,984
|
|
|
145,297
|
|
||
Other noncurrent liabilities
|
4,830
|
|
|
5,237
|
|
||
Total liabilities
|
1,502,835
|
|
|
1,325,583
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock - $.01 par value, authorized 5,000,000 shares, no shares issued
|
—
|
|
|
—
|
|
||
Common stock - $.01 par value, authorized 150,000,000 shares, issued 106,548,957 and 105,840,586 shares
|
1,066
|
|
|
1,058
|
|
||
Additional paid-in capital
|
1,103,357
|
|
|
1,073,671
|
|
||
Retained earnings
|
885,763
|
|
|
797,514
|
|
||
Accumulated other comprehensive loss
|
(107,577
|
)
|
|
(42,406
|
)
|
||
|
1,882,609
|
|
|
1,829,837
|
|
||
Less: 3,447,946 and 3,229,342 shares of treasury stock, at cost
|
(68,584
|
)
|
|
(58,150
|
)
|
||
Total stockholders’ equity
|
1,814,025
|
|
|
1,771,687
|
|
||
Total liabilities and stockholders’ equity
|
$
|
3,316,860
|
|
|
$
|
3,097,270
|
|
|
Three Months Ended December 31,
|
|
Six Months Ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Net sales
|
$
|
752,589
|
|
|
$
|
696,383
|
|
|
$
|
1,439,777
|
|
|
$
|
1,327,640
|
|
Cost of sales
|
575,026
|
|
|
529,056
|
|
|
1,110,167
|
|
|
1,034,469
|
|
||||
Gross profit
|
177,563
|
|
|
167,327
|
|
|
329,610
|
|
|
293,171
|
|
||||
Selling, general and administrative expenses
|
82,607
|
|
|
88,621
|
|
|
168,861
|
|
|
179,544
|
|
||||
Amortization of acquired intangibles
|
4,736
|
|
|
4,303
|
|
|
9,408
|
|
|
8,813
|
|
||||
Acquisition related expenses, restructuring and integration charges, net
|
2,498
|
|
|
391
|
|
|
6,151
|
|
|
1,975
|
|
||||
Operating income
|
87,722
|
|
|
74,012
|
|
|
145,190
|
|
|
102,839
|
|
||||
Interest and other expenses, net
|
9,365
|
|
|
8,814
|
|
|
21,233
|
|
|
12,740
|
|
||||
Income before income taxes and equity in earnings of equity-method investees
|
78,357
|
|
|
65,198
|
|
|
123,957
|
|
|
90,099
|
|
||||
Provision for income taxes
|
21,379
|
|
|
20,931
|
|
|
35,761
|
|
|
26,997
|
|
||||
Equity in net loss (income) of equity-method investees
|
31
|
|
|
(308
|
)
|
|
(53
|
)
|
|
(328
|
)
|
||||
Net income
|
$
|
56,947
|
|
|
$
|
44,575
|
|
|
$
|
88,249
|
|
|
$
|
63,430
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per common share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.55
|
|
|
$
|
0.44
|
|
|
$
|
0.86
|
|
|
$
|
0.63
|
|
Diluted
|
$
|
0.55
|
|
|
$
|
0.43
|
|
|
$
|
0.85
|
|
|
$
|
0.62
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
103,017
|
|
|
101,267
|
|
|
102,912
|
|
|
100,975
|
|
||||
Diluted
|
104,161
|
|
|
103,226
|
|
|
104,209
|
|
|
102,941
|
|
|
Three Months Ended
|
||||||||||||||||||||||
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
||||||||||||
Net income
|
|
|
|
|
$
|
56,947
|
|
|
|
|
|
|
$
|
44,575
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign currency translation adjustments
|
$
|
(25,791
|
)
|
|
$
|
—
|
|
|
(25,791
|
)
|
|
$
|
(51,656
|
)
|
|
$
|
1,289
|
|
|
(50,367
|
)
|
||
Change in deferred gains (losses) on cash flow hedging instruments
|
(418
|
)
|
|
122
|
|
|
(296
|
)
|
|
(100
|
)
|
|
913
|
|
|
813
|
|
||||||
Change in unrealized gain on available for sale investment
|
39
|
|
|
(15
|
)
|
|
24
|
|
|
(492
|
)
|
|
192
|
|
|
(300
|
)
|
||||||
Total other comprehensive income (loss)
|
$
|
(26,170
|
)
|
|
$
|
107
|
|
|
$
|
(26,063
|
)
|
|
$
|
(52,248
|
)
|
|
$
|
2,394
|
|
|
$
|
(49,854
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total comprehensive (loss) income
|
|
|
|
|
$
|
30,884
|
|
|
|
|
|
|
$
|
(5,279
|
)
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Six Months Ended
|
||||||||||||||||||||||
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
|
Pre-tax
amount
|
|
Tax (expense) benefit
|
|
After-tax amount
|
||||||||||||
Net income
|
|
|
|
|
$
|
88,249
|
|
|
|
|
|
|
$
|
63,430
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign currency translation adjustments
|
$
|
(66,084
|
)
|
|
$
|
—
|
|
|
(66,084
|
)
|
|
$
|
(112,698
|
)
|
|
$
|
2,729
|
|
|
(109,969
|
)
|
||
Change in deferred gains (losses) on cash flow hedging instruments
|
1,322
|
|
|
(277
|
)
|
|
1,045
|
|
|
2,305
|
|
|
(526
|
)
|
|
1,779
|
|
||||||
Change in unrealized gain on available for sale investment
|
(216
|
)
|
|
84
|
|
|
(132
|
)
|
|
(1,343
|
)
|
|
455
|
|
|
(888
|
)
|
||||||
Total other comprehensive income (loss)
|
$
|
(64,978
|
)
|
|
$
|
(193
|
)
|
|
$
|
(65,171
|
)
|
|
$
|
(111,736
|
)
|
|
$
|
2,658
|
|
|
$
|
(109,078
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total comprehensive (loss) income
|
|
|
|
|
$
|
23,078
|
|
|
|
|
|
|
$
|
(45,648
|
)
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
Additional
|
|
|
|
|
|
|
|
Accumulated
Other
|
|
|
||||||||||||||||
|
|
|
Amount
|
|
Paid-in
|
|
Retained
|
|
Treasury Stock
|
|
Comprehensive
|
|
|
||||||||||||||||
|
Shares
|
|
at $.01
|
|
Capital
|
|
Earnings
|
|
Shares
|
|
Amount
|
|
Income (Loss)
|
|
Total
|
||||||||||||||
Balance at June 30, 2015
|
105,840,586
|
|
|
$
|
1,058
|
|
|
$
|
1,073,671
|
|
|
$
|
797,514
|
|
|
3,229,342
|
|
|
$
|
(58,150
|
)
|
|
$
|
(42,406
|
)
|
|
$
|
1,771,687
|
|
Net income
|
|
|
|
|
|
|
88,249
|
|
|
|
|
|
|
|
|
88,249
|
|
||||||||||||
Other comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
(65,171
|
)
|
|
(65,171
|
)
|
||||||||||||
Issuance of common stock pursuant to stock based compensation plans
|
468,164
|
|
|
5
|
|
|
4,395
|
|
|
|
|
|
|
|
|
|
|
4,400
|
|
||||||||||
Issuance of common stock in connection with acquisitions
|
240,207
|
|
|
3
|
|
|
16,305
|
|
|
|
|
|
|
|
|
|
|
16,308
|
|
||||||||||
Stock based compensation income tax effects
|
|
|
|
|
1,757
|
|
|
|
|
|
|
|
|
|
|
1,757
|
|
||||||||||||
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans
|
|
|
|
|
|
|
|
|
218,604
|
|
|
(10,434
|
)
|
|
|
|
(10,434
|
)
|
|||||||||||
Stock based compensation charge
|
|
|
|
|
7,229
|
|
|
|
|
|
|
|
|
|
|
7,229
|
|
||||||||||||
Balance at December 31, 2015
|
106,548,957
|
|
|
1,066
|
|
|
1,103,357
|
|
|
885,763
|
|
|
3,447,946
|
|
|
(68,584
|
)
|
|
(107,577
|
)
|
|
1,814,025
|
|
|
Six Months Ended December 31,
|
||||||
|
2015
|
|
2014
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
||||
Net income
|
$
|
88,249
|
|
|
$
|
63,430
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
||||
Depreciation and amortization
|
31,409
|
|
|
28,902
|
|
||
Deferred income taxes
|
(8,693
|
)
|
|
(5,044
|
)
|
||
Equity in net income of equity-method investees
|
(53
|
)
|
|
(328
|
)
|
||
Stock based compensation
|
7,229
|
|
|
5,999
|
|
||
Tax (deficiency) benefit from stock based compensation
|
(258
|
)
|
|
2,131
|
|
||
Contingent consideration expense
|
—
|
|
|
280
|
|
||
Gain on pre-existing ownership interest in Hain Pure Protein Corporation
|
—
|
|
|
(5,334
|
)
|
||
Other non-cash items including unrealized currency (gains)/losses, net
|
7,812
|
|
|
(2,811
|
)
|
||
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
|
|
|
|
||||
Accounts receivable
|
(17,231
|
)
|
|
(41,559
|
)
|
||
Inventories
|
(20,891
|
)
|
|
(26,244
|
)
|
||
Other current assets
|
5,336
|
|
|
(1,228
|
)
|
||
Other assets and liabilities
|
2,187
|
|
|
(5,254
|
)
|
||
Accounts payable and accrued expenses
|
4,548
|
|
|
41,311
|
|
||
Net cash provided by operating activities
|
99,644
|
|
|
54,251
|
|
||
|
|
|
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
||||
Acquisitions of businesses, net of cash acquired and working capital settlements
|
(157,864
|
)
|
|
(17,935
|
)
|
||
Purchases of property and equipment
|
(41,177
|
)
|
|
(25,766
|
)
|
||
Proceeds from sale of investment
|
—
|
|
|
1,287
|
|
||
Proceeds from disposals of property and equipment
|
—
|
|
|
1,697
|
|
||
Net cash used in investing activities
|
(199,041
|
)
|
|
(40,717
|
)
|
||
|
|
|
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
||||
Proceeds from exercises of stock options
|
—
|
|
|
9,728
|
|
||
Borrowings under bank revolving credit facility, net
|
121,969
|
|
|
21,500
|
|
||
Borrowings (repayments) of other debt, net
|
780
|
|
|
(23,411
|
)
|
||
Excess tax benefits from stock based compensation
|
2,016
|
|
|
13,615
|
|
||
Acquisition related contingent consideration
|
—
|
|
|
(3,217
|
)
|
||
Shares withheld for payment of employee payroll taxes
|
(10,434
|
)
|
|
(12,174
|
)
|
||
Net cash provided by financing activities
|
114,331
|
|
|
6,041
|
|
||
|
|
|
|
||||
Effect of exchange rate changes on cash
|
(4,756
|
)
|
|
(8,099
|
)
|
||
|
|
|
|
||||
Net increase in cash and cash equivalents
|
10,178
|
|
|
11,476
|
|
||
Cash and cash equivalents at beginning of period
|
166,922
|
|
|
123,751
|
|
||
Cash and cash equivalents at end of period
|
$
|
177,100
|
|
|
$
|
135,227
|
|
|
Three Months Ended December 31,
|
|
Six Months Ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
56,947
|
|
|
$
|
44,575
|
|
|
$
|
88,249
|
|
|
$
|
63,430
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator for basic earnings per share - weighted average shares
outstanding during the period (
in thousands
)
|
103,017
|
|
|
101,267
|
|
|
102,912
|
|
|
100,975
|
|
||||
Effect of dilutive stock options, unvested restricted stock and unvested
restricted share units (
in thousands
)
|
1,144
|
|
|
1,959
|
|
|
1,297
|
|
|
1,966
|
|
||||
Denominator for diluted earnings per share - adjusted weighted
average shares and assumed conversions (
in thousands
)
|
104,161
|
|
|
103,226
|
|
|
104,209
|
|
|
102,941
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Basic earnings per share
|
$
|
0.55
|
|
|
$
|
0.44
|
|
|
$
|
0.86
|
|
|
$
|
0.63
|
|
Diluted earnings per share
|
$
|
0.55
|
|
|
$
|
0.43
|
|
|
$
|
0.85
|
|
|
$
|
0.62
|
|
|
Mona
|
|
Orchard House
|
|
Total
|
||||||
Purchase Price:
|
|
|
|
|
|
||||||
Cash paid
|
$
|
25,233
|
|
|
$
|
114,113
|
|
|
$
|
139,346
|
|
Equity issued
|
16,308
|
|
|
—
|
|
|
16,308
|
|
|||
Fair value of contingent consideration
|
—
|
|
|
2,225
|
|
|
2,225
|
|
|||
Total investment:
|
$
|
41,541
|
|
|
$
|
116,338
|
|
|
$
|
157,879
|
|
Allocation:
|
|
|
|
|
|
||||||
Current assets
|
$
|
17,801
|
|
|
$
|
28,374
|
|
|
$
|
46,175
|
|
Property, plant and equipment
|
16,391
|
|
|
17,707
|
|
|
34,098
|
|
|||
Other long term assets
|
226
|
|
|
—
|
|
|
226
|
|
|||
Identifiable intangible assets
|
16,617
|
|
|
24,032
|
|
|
40,649
|
|
|||
Deferred taxes
|
(3,739
|
)
|
|
(4,326
|
)
|
|
(8,065
|
)
|
|||
Assumed liabilities
|
(27,093
|
)
|
|
(42,190
|
)
|
|
(69,283
|
)
|
|||
Goodwill
|
21,338
|
|
|
92,741
|
|
|
114,079
|
|
|||
|
$
|
41,541
|
|
|
$
|
116,338
|
|
|
$
|
157,879
|
|
|
Three Months ended December 31,
|
|
Six Months ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Net sales
|
$
|
790,446
|
|
|
$
|
748,572
|
|
|
$
|
1,528,289
|
|
|
$
|
1,443,598
|
|
Net income
|
$
|
57,524
|
|
|
$
|
44,831
|
|
|
$
|
91,998
|
|
|
$
|
66,571
|
|
Net income per diluted common share
|
$
|
0.55
|
|
|
$
|
0.43
|
|
|
$
|
0.88
|
|
|
$
|
0.65
|
|
|
HPPC
|
|
Belvedere
|
|
Empire
|
|
Total
|
||||||||
Carrying value of pre-existing interest, after fair value adjustments:
|
$
|
36,074
|
|
|
$
|
—
|
|
|
$
|
9,786
|
|
|
$
|
45,860
|
|
Purchase Price:
|
|
|
|
|
|
|
|
||||||||
Cash paid
|
20,310
|
|
|
13,988
|
|
|
57,595
|
|
|
91,893
|
|
||||
Equity issued
|
19,690
|
|
|
—
|
|
|
—
|
|
|
19,690
|
|
||||
Fair value of contingent consideration
|
—
|
|
|
1,603
|
|
|
—
|
|
|
1,603
|
|
||||
Total investment:
|
$
|
76,074
|
|
|
$
|
15,591
|
|
|
$
|
67,381
|
|
|
$
|
159,046
|
|
Allocation:
|
|
|
|
|
|
|
|
||||||||
Current assets
|
$
|
52,055
|
|
|
$
|
10,042
|
|
|
$
|
19,629
|
|
|
$
|
81,726
|
|
Property, plant and equipment
|
21,864
|
|
|
2,598
|
|
|
13,094
|
|
|
37,556
|
|
||||
Other assets
|
7,288
|
|
|
—
|
|
|
—
|
|
|
7,288
|
|
||||
Identifiable intangible assets
|
20,700
|
|
|
5,850
|
|
|
34,800
|
|
|
61,350
|
|
||||
Deferred taxes
|
1,388
|
|
|
(3,890
|
)
|
|
(14,668
|
)
|
|
(17,170
|
)
|
||||
Assumed liabilities
|
(42,332
|
)
|
|
(1,825
|
)
|
|
(15,987
|
)
|
|
(60,144
|
)
|
||||
Goodwill
|
15,111
|
|
|
2,816
|
|
|
30,513
|
|
|
48,440
|
|
||||
|
$
|
76,074
|
|
|
$
|
15,591
|
|
|
$
|
67,381
|
|
|
$
|
159,046
|
|
|
Three Months ended December 31, 2014
|
|
Six Months ended December 31, 2014
|
||||
Net sales
|
$
|
738,858
|
|
|
$
|
1,412,780
|
|
Net income
|
$
|
46,299
|
|
|
$
|
67,092
|
|
Net income per diluted common share
|
$
|
0.45
|
|
|
$
|
0.65
|
|
|
December 31,
2015 |
|
June 30,
2015 |
||||
Finished goods
|
$
|
212,532
|
|
|
$
|
240,004
|
|
Raw materials, work-in-progress and packaging
|
190,786
|
|
|
142,207
|
|
||
|
$
|
403,318
|
|
|
$
|
382,211
|
|
|
December 31,
2015 |
|
June 30,
2015 |
||||
Land
|
$
|
36,459
|
|
|
$
|
36,386
|
|
Buildings and improvements
|
96,710
|
|
|
88,507
|
|
||
Machinery and equipment
|
380,558
|
|
|
359,183
|
|
||
Furniture and fixtures
|
13,029
|
|
|
10,272
|
|
||
Leasehold improvements
|
21,309
|
|
|
19,257
|
|
||
Construction in progress
|
28,113
|
|
|
11,444
|
|
||
|
576,178
|
|
|
525,049
|
|
||
Less: Accumulated depreciation and amortization
|
193,348
|
|
|
180,787
|
|
||
|
$
|
382,830
|
|
|
$
|
344,262
|
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Total
|
||||||||||
Balance as of June 30, 2015 (a)
|
$
|
607,843
|
|
|
$
|
420,166
|
|
|
$
|
45,328
|
|
|
$
|
62,742
|
|
|
$
|
1,136,079
|
|
Acquisition activity
|
—
|
|
|
92,741
|
|
|
297
|
|
|
21,237
|
|
|
114,275
|
|
|||||
Translation adjustments
|
(1,951
|
)
|
|
(23,441
|
)
|
|
—
|
|
|
(5,237
|
)
|
|
(30,629
|
)
|
|||||
Balance as of December 31, 2015 (a)
|
$
|
605,892
|
|
|
$
|
489,466
|
|
|
$
|
45,625
|
|
|
$
|
78,742
|
|
|
$
|
1,219,725
|
|
|
December 31,
2015 |
|
June 30,
2015 |
||||
Non-amortized intangible assets:
|
|
|
|
||||
Trademarks and tradenames
|
$
|
503,520
|
|
|
$
|
507,853
|
|
Amortized intangible assets:
|
|
|
|
||||
Other intangibles
|
230,807
|
|
|
207,609
|
|
||
Less: accumulated amortization
|
(75,060
|
)
|
|
(67,708
|
)
|
||
Net carrying amount
|
$
|
659,267
|
|
|
$
|
647,754
|
|
|
Three Months ended December 31,
|
|
Six Months ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Amortization of intangible assets
|
$
|
4,736
|
|
|
$
|
4,303
|
|
|
$
|
9,408
|
|
|
$
|
8,813
|
|
|
Fiscal Year ended June 30,
|
||||||||||||||||||
|
2016
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
||||||||||
Estimated amortization expense
|
$
|
19,804
|
|
|
$
|
19,514
|
|
|
$
|
18,363
|
|
|
$
|
16,400
|
|
|
$
|
16,455
|
|
|
December 31,
2015 |
|
June 30,
2015 |
||||
Senior Notes
|
$
|
150,000
|
|
|
$
|
150,000
|
|
Revolving Credit Agreement borrowings payable to banks
|
780,882
|
|
|
660,216
|
|
||
Tilda short-term borrowing arrangements
|
35,898
|
|
|
29,600
|
|
||
Other borrowings
|
15,234
|
|
|
4,067
|
|
||
|
982,014
|
|
|
843,883
|
|
||
Short-term borrowings and current portion of long-term debt
|
41,552
|
|
|
31,275
|
|
||
|
$
|
940,462
|
|
|
$
|
812,608
|
|
|
Three Months Ended December 31,
|
|
Six Months Ended
December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income (loss) before reclassifications
(1)
|
$
|
(25,791
|
)
|
|
$
|
(50,367
|
)
|
|
$
|
(66,084
|
)
|
|
$
|
(109,969
|
)
|
Amounts reclassified into income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Deferred gains/(losses) on cash flow hedging instruments:
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income (loss) before reclassifications
|
1,118
|
|
|
2,919
|
|
|
3,271
|
|
|
4,429
|
|
||||
Amounts reclassified into income
(2)
|
(1,414
|
)
|
|
(2,106
|
)
|
|
(2,226
|
)
|
|
(2,650
|
)
|
||||
Unrealized gain/(loss) on available for sale investment:
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income (loss) before reclassifications
|
24
|
|
|
(300
|
)
|
|
(132
|
)
|
|
(699
|
)
|
||||
Amounts reclassified into income
(3)
|
—
|
|
|
—
|
|
|
—
|
|
|
(189
|
)
|
||||
Net change in accumulated other comprehensive income (loss)
|
$
|
(26,063
|
)
|
|
$
|
(49,854
|
)
|
|
$
|
(65,171
|
)
|
|
$
|
(109,078
|
)
|
(1)
|
Foreign currency translation adjustments include intra-entity foreign currency transactions that are of a long-term investment nature of
$24,201
and
$20,058
for the three months ended
December 31, 2015
and
2014
,
respectively, and
$38,916
and
$43,106
for the six months ended
December 31, 2015
and
2014
, respectively.
|
(2)
|
Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were
$1,862
and
$2,700
for the three months ended
December 31, 2015
and
2014
, respectively
$2,946
and
$3,415
for the six months ended
December 31, 2015
and
2014
, respectively.
|
(3)
|
Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 12). Such amounts are recorded in “Interest and other expenses, net” in the Condensed Consolidated Statements of Income and were
$311
before taxes for the six months ended
December 31, 2014
.
|
|
Three Months Ended December 31,
|
|
Six Months Ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Compensation cost (included in selling, general and administrative expense)
|
$
|
4,023
|
|
|
$
|
3,060
|
|
|
$
|
7,229
|
|
|
$
|
5,999
|
|
Related income tax benefit
|
$
|
1,499
|
|
|
$
|
1,188
|
|
|
$
|
2,710
|
|
|
$
|
2,313
|
|
|
Number of Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Contractual
Life (years)
|
|
Aggregate
Intrinsic Value
|
|||||
Options outstanding and exercisable at June 30, 2015
|
1,248,912
|
|
|
$
|
6.12
|
|
|
|
|
|
||
Exercised
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Options outstanding and exercisable at December 31, 2015
|
1,248,912
|
|
|
$
|
6.12
|
|
|
1.8 years
|
|
$
|
42,806
|
|
|
Six Months Ended December 31,
|
||||||
|
2015
|
|
2014
|
||||
Intrinsic value of options exercised
|
$
|
—
|
|
|
$
|
28,612
|
|
Cash received from stock option exercises
|
$
|
—
|
|
|
$
|
9,728
|
|
Tax benefit recognized from stock option exercises
|
$
|
—
|
|
|
$
|
11,109
|
|
|
Number of Shares
and Units
|
|
Weighted
Average Grant
Date Fair
Value (per share)
|
|||
Non-vested restricted stock, restricted share units, and performance units at June 30, 2015
|
1,145,042
|
|
|
$
|
32.30
|
|
Granted
|
402,564
|
|
|
$
|
24.00
|
|
Vested
|
(385,537
|
)
|
|
$
|
33.72
|
|
Forfeited
|
(22,464
|
)
|
|
$
|
47.51
|
|
Non-vested restricted stock, restricted share units, and performance units at December 31, 2015
|
1,139,605
|
|
|
$
|
28.83
|
|
|
Six Months Ended December 31,
|
||||||
|
2015
|
|
2014
|
||||
Fair value of restricted stock, restricted share units, and performance units granted
|
$
|
9,660
|
|
|
$
|
14,255
|
|
Fair value of shares vested
|
$
|
17,855
|
|
|
$
|
21,121
|
|
Tax benefit recognized from restricted shares vesting
|
$
|
6,743
|
|
|
$
|
8,223
|
|
•
|
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
|
•
|
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;
|
•
|
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
|
|
Total
|
|
Quoted
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
$
|
54,003
|
|
|
$
|
54,003
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Forward foreign currency contracts
|
2,575
|
|
|
—
|
|
|
2,575
|
|
|
—
|
|
||||
Available for sale securities
|
981
|
|
|
981
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
57,559
|
|
|
$
|
54,984
|
|
|
$
|
2,575
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Forward foreign currency contracts
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Contingent consideration, of which $2,479 is noncurrent
|
5,779
|
|
|
—
|
|
|
—
|
|
|
5,779
|
|
||||
Total
|
$
|
5,779
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,779
|
|
|
Total
|
|
Quoted
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
$
|
45,101
|
|
|
$
|
45,101
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Forward foreign currency contracts
|
1,590
|
|
|
—
|
|
|
1,590
|
|
|
—
|
|
||||
Available for sale securities
|
1,196
|
|
|
1,196
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
47,887
|
|
|
$
|
46,297
|
|
|
$
|
1,590
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Forward foreign currency contracts
|
$
|
274
|
|
|
$
|
—
|
|
|
$
|
274
|
|
|
$
|
—
|
|
Contingent consideration, of which $3,789 is noncurrent
|
3,789
|
|
|
—
|
|
|
—
|
|
|
3,789
|
|
||||
Total
|
$
|
4,063
|
|
|
$
|
—
|
|
|
$
|
274
|
|
|
$
|
3,789
|
|
Balance as of June 30, 2015
|
$
|
3,789
|
|
Fair value of initial contingent consideration
|
2,225
|
|
|
Translation adjustment
|
(235
|
)
|
|
Balance as of December 31, 2015
|
$
|
5,779
|
|
|
Three Months Ended December 31,
|
|
Six Months Ended December 31,
|
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Net Sales:
|
|
|
|
|
|
|
|
||||||||
United States
|
$
|
342,298
|
|
|
$
|
353,969
|
|
|
$
|
673,511
|
|
|
$
|
690,884
|
|
United Kingdom
|
194,226
|
|
|
200,797
|
|
|
359,580
|
|
|
373,076
|
|
||||
Hain Pure Protein
|
141,706
|
|
|
86,216
|
|
|
265,694
|
|
|
156,886
|
|
||||
Rest of World
|
74,359
|
|
|
55,401
|
|
|
140,992
|
|
|
106,794
|
|
||||
|
$
|
752,589
|
|
|
$
|
696,383
|
|
|
$
|
1,439,777
|
|
|
$
|
1,327,640
|
|
|
|
|
|
|
|
|
|
||||||||
Operating Income:
|
|
|
|
|
|
|
|
||||||||
United States
|
$
|
50,221
|
|
|
$
|
55,591
|
|
|
$
|
94,687
|
|
|
$
|
85,181
|
|
United Kingdom
|
18,768
|
|
|
12,263
|
|
|
28,972
|
|
|
17,858
|
|
||||
Hain Pure Protein
|
18,125
|
|
|
7,715
|
|
|
28,396
|
|
|
11,534
|
|
||||
Rest of World
|
4,689
|
|
|
5,613
|
|
|
6,784
|
|
|
6,248
|
|
||||
|
$
|
91,803
|
|
|
$
|
81,182
|
|
|
$
|
158,839
|
|
|
$
|
120,821
|
|
Corporate and other
(1)
|
(4,081
|
)
|
|
(7,170
|
)
|
|
(13,649
|
)
|
|
(17,982
|
)
|
||||
|
$
|
87,722
|
|
|
$
|
74,012
|
|
|
$
|
145,190
|
|
|
$
|
102,839
|
|
(1)
|
Includes
$2,498
and
$359
of acquisition related expenses, restructuring and integration charges for the three months ended
December 31, 2015
and
2014
, respectively. Such expenses for the six months ended
December 31, 2015
and
2014
were
$4,591
and
$1,662
, respectively. Corporate and other also includes expense of
$280
for contingent consideration adjustments (see Note 13) for the six months ended
December 31, 2014
.
|
|
Three Months Ended
|
||||||||||
|
December 31, 2015
|
|
December 31, 2014
|
||||||||
Net sales
|
$
|
752,589
|
|
|
100.0%
|
|
$
|
696,383
|
|
|
100.0%
|
Cost of sales
|
575,026
|
|
|
76.4%
|
|
529,056
|
|
|
76.0%
|
||
Gross profit
|
177,563
|
|
|
23.6%
|
|
167,327
|
|
|
24.0%
|
||
|
|
|
|
|
|
|
|
||||
Selling, general and administrative expenses
|
82,607
|
|
|
11.0%
|
|
88,621
|
|
|
12.7%
|
||
Amortization/impairment of acquired intangibles
|
4,736
|
|
|
0.6%
|
|
4,303
|
|
|
0.6%
|
||
Acquisition related expenses, restructuring and integration charges, net
|
2,498
|
|
|
0.3%
|
|
391
|
|
|
0.1%
|
||
Operating income
|
87,722
|
|
|
11.7%
|
|
74,012
|
|
|
10.6%
|
||
Interest and other expenses, net
|
9,365
|
|
|
1.2%
|
|
8,814
|
|
|
1.3%
|
||
Income before income taxes and equity in earnings of equity-method investees
|
78,357
|
|
|
10.4%
|
|
65,198
|
|
|
9.4%
|
||
Provision for income taxes
|
21,379
|
|
|
2.8%
|
|
20,931
|
|
|
3.0%
|
||
Equity in net loss (income) of equity-method investees
|
31
|
|
|
—%
|
|
(308
|
)
|
|
—%
|
||
Net income
|
$
|
56,947
|
|
|
7.6%
|
|
$
|
44,575
|
|
|
6.4%
|
(dollars in thousands)
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Corporate and other
(1)
|
|
Consolidated
|
||||||||||||
Net sales - Three months ended 12/31/15
|
|
$
|
342,298
|
|
|
$
|
194,226
|
|
|
$
|
141,706
|
|
|
$
|
74,359
|
|
|
$
|
—
|
|
|
$
|
752,589
|
|
Net sales - Three months ended 12/31/14
|
|
$
|
353,969
|
|
|
$
|
200,797
|
|
|
$
|
86,216
|
|
|
$
|
55,401
|
|
|
$
|
—
|
|
|
$
|
696,383
|
|
% change
|
|
(3.3
|
)%
|
|
(3.3
|
)%
|
|
64.4
|
%
|
|
34.2
|
%
|
|
|
|
8.1
|
%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Operating income - Three months ended 12/31/15
|
|
$
|
50,221
|
|
|
$
|
18,768
|
|
|
$
|
18,125
|
|
|
$
|
4,689
|
|
|
$
|
(4,081
|
)
|
|
$
|
87,722
|
|
Operating income - Three months ended 12/31/14
|
|
$
|
55,591
|
|
|
$
|
12,263
|
|
|
$
|
7,715
|
|
|
$
|
5,613
|
|
|
$
|
(7,170
|
)
|
|
$
|
74,012
|
|
% change
|
|
(9.7
|
)%
|
|
53.0
|
%
|
|
134.9
|
%
|
|
(16.5
|
)%
|
|
|
|
18.5
|
%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Operating income margin - Three months ended 12/31/15
|
|
14.7
|
%
|
|
9.7
|
%
|
|
12.8
|
%
|
|
6.3
|
%
|
|
|
|
11.7
|
%
|
|||||||
Operating income margin - Three months ended 12/31/14
|
|
15.7
|
%
|
|
6.1
|
%
|
|
8.9
|
%
|
|
10.1
|
%
|
|
|
|
10.6
|
%
|
(1)
|
Includes
$2,498
and
$359
of acquisition related expenses, restructuring and integration charges for the three months ended
December 31, 2015
and
2014
, respectively.
|
|
Six Months Ended
|
||||||||||
|
December 31, 2015
|
|
December 31, 2014
|
||||||||
Net sales
|
$
|
1,439,777
|
|
|
100.0%
|
|
$
|
1,327,640
|
|
|
100.0%
|
Cost of sales
|
1,110,167
|
|
|
77.1%
|
|
1,034,469
|
|
|
77.9%
|
||
Gross profit
|
329,610
|
|
|
22.9%
|
|
293,171
|
|
|
22.1%
|
||
|
|
|
|
|
|
|
|
||||
Selling, general and administrative expenses
|
168,861
|
|
|
11.7%
|
|
179,544
|
|
|
13.5%
|
||
Amortization/impairment of acquired intangibles
|
9,408
|
|
|
0.7%
|
|
8,813
|
|
|
0.7%
|
||
Acquisition related expenses, restructuring and integration charges, net
|
6,151
|
|
|
0.4%
|
|
1,975
|
|
|
0.1%
|
||
Operating income
|
145,190
|
|
|
10.1%
|
|
102,839
|
|
|
7.7%
|
||
Interest and other expenses, net
|
21,233
|
|
|
1.5%
|
|
12,740
|
|
|
1.0%
|
||
Income before income taxes and equity in earnings of equity-method investees
|
123,957
|
|
|
8.6%
|
|
90,099
|
|
|
6.8%
|
||
Provision for income taxes
|
35,761
|
|
|
2.5%
|
|
26,997
|
|
|
2.0%
|
||
Equity in net loss (income) of equity-method investees
|
(53
|
)
|
|
—%
|
|
(328
|
)
|
|
—%
|
||
Net income
|
$
|
88,249
|
|
|
6.1%
|
|
$
|
63,430
|
|
|
4.8%
|
(dollars in thousands)
|
|
United States
|
|
United Kingdom
|
|
Hain Pure Protein
|
|
Rest of World
|
|
Corporate and other
(1)
|
|
Consolidated
|
||||||||||||
Net sales - Six months ended 12/31/15
|
|
$
|
673,511
|
|
|
$
|
359,580
|
|
|
$
|
265,694
|
|
|
$
|
140,992
|
|
|
$
|
—
|
|
|
$
|
1,439,777
|
|
Net sales - Six months ended 12/31/14
|
|
$
|
690,884
|
|
|
$
|
373,076
|
|
|
$
|
156,886
|
|
|
106,794
|
|
|
$
|
—
|
|
|
$
|
1,327,640
|
|
|
% change
|
|
(2.5
|
)%
|
|
(3.6
|
)%
|
|
69.4
|
%
|
|
32.0
|
%
|
|
|
|
8.4
|
%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Operating income - Six months ended 12/31/15
|
|
$
|
94,687
|
|
|
$
|
28,972
|
|
|
$
|
28,396
|
|
|
$
|
6,784
|
|
|
$
|
(13,649
|
)
|
|
$
|
145,190
|
|
Operating income - Six months ended 12/31/14
|
|
$
|
85,181
|
|
|
$
|
17,858
|
|
|
$
|
11,534
|
|
|
$
|
6,248
|
|
|
$
|
(17,982
|
)
|
|
$
|
102,839
|
|
% change
|
|
11.2
|
%
|
|
62.2
|
%
|
|
146.2
|
%
|
|
8.6
|
%
|
|
|
|
41.2
|
%
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Operating income margin - Six months ended 12/31/15
|
|
14.1
|
%
|
|
8.1
|
%
|
|
10.7
|
%
|
|
4.8
|
%
|
|
|
|
10.1
|
%
|
|||||||
Operating income margin - Six months ended 12/31/14
|
|
12.3
|
%
|
|
4.8
|
%
|
|
7.4
|
%
|
|
5.9
|
%
|
|
|
|
7.7
|
%
|
(1)
|
Includes
$4,591
and
$1,662
of acquisition related expenses, restructuring and integration charges for the six months ended
December 31, 2015
and
2014
, respectively. Corporate and other also includes expense of
$280
for contingent consideration adjustments for the six months ended December 31, 2014.
|
|
Six Months Ended December 31,
|
||||||
(amounts in thousands)
|
2015
|
|
2014
|
||||
Cash flows provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
99,644
|
|
|
$
|
54,251
|
|
Investing activities
|
(199,041
|
)
|
|
(40,717
|
)
|
||
Financing activities
|
114,331
|
|
|
6,041
|
|
||
Effect of exchange rate changes on cash
|
(4,756
|
)
|
|
(8,099
|
)
|
||
Net increase in cash
|
$
|
10,178
|
|
|
$
|
11,476
|
|
|
Six Months Ended December 31,
|
||||||
(amounts in thousands)
|
2015
|
|
2014
|
||||
Cash flow provided by operating activities
|
$
|
99,644
|
|
|
$
|
54,251
|
|
Purchase of property, plant and equipment
|
(41,177
|
)
|
|
(25,766
|
)
|
||
Operating free cash flow
|
$
|
58,467
|
|
|
$
|
28,485
|
|
•
|
general economic and financial market conditions;
|
•
|
competition;
|
•
|
our ability to respond to changes and trends in customer and consumer demand, preferences and consumption;
|
•
|
our reliance on third party distributors, manufacturers and suppliers;
|
•
|
the consolidation or loss of a significant customer;
|
•
|
our ability to introduce new products and improve existing products;
|
•
|
availability and retention of key personnel;
|
•
|
our ability to effectively integrate our acquisitions;
|
•
|
our ability to successfully consummate any proposed divestitures;
|
•
|
liabilities arising from potential product recalls, market withdrawals or product liability claims;
|
•
|
outbreaks of diseases or food-borne illnesses;
|
•
|
potential litigation;
|
•
|
the availability of organic and natural ingredients;
|
•
|
our ability to manage our supply chain effectively;
|
•
|
changes in fuel, raw material and commodity costs;
|
•
|
effects of climate change on our business and operations;
|
•
|
our ability to offset input cost increases;
|
•
|
the interruption, disruption or loss of operations at one or more of our manufacturing facilities;
|
•
|
the loss of one or more of our independent co-packers;
|
•
|
the disruption of our transportation systems;
|
•
|
risks associated with expansion into countries in which we have no prior operating experience;
|
•
|
risks associated with our international sales and operations, including foreign currency risks;
|
•
|
impairment in the carrying value of our goodwill or other intangible assets;
|
•
|
our ability to use our trademarks;
|
•
|
reputational damage;
|
•
|
changes in, or the failure to comply with, government laws and regulations;
|
•
|
liabilities or claims with respect to environmental matters;
|
•
|
our reliance on independent certification for our products;
|
•
|
a breach of security measures;
|
•
|
our reliance on our information technology systems;
|
•
|
effects of general global capital and credit market issues on our liquidity and cost of borrowing;
|
•
|
potential liabilities not covered by insurance;
|
•
|
the ability of joint venture investments to successfully execute business plans;
|
•
|
dilution in the value of our common shares; and
|
•
|
the other risk factors described in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2015.
|
Period
|
(a)
Total number
of shares
purchased (1)
|
|
(b)
Average
price paid
per share
|
|
(c)
Total number of
shares purchased
as part of
publicly
announced plans
|
|
(d)
Maximum
number of shares
that may yet be
purchased under
the plans
|
|||||
October 2015
|
62,051
|
|
|
$
|
52.89
|
|
|
—
|
|
|
—
|
|
November 2015
|
84,857
|
|
|
41.09
|
|
|
—
|
|
|
—
|
|
|
December 2015
|
22,363
|
|
|
38.42
|
|
|
—
|
|
|
—
|
|
|
Total
|
169,271
|
|
|
$
|
45.06
|
|
|
—
|
|
|
—
|
|
(1)
|
Shares surrendered for payment of employee payroll taxes due on shares issued under stockholder approved stock based compensation plans.
|
|
|
THE HAIN CELESTIAL GROUP, INC.
|
|
|
|
Date:
|
February 9, 2016
|
/s/ Irwin D. Simon
|
|
|
Irwin D. Simon,
Chairman, President and Chief
Executive Officer
|
Date:
|
February 9, 2016
|
/s/ Pasquale Conte
|
|
|
Pasquale Conte,
Executive Vice President and
Chief Financial Officer
|
Exhibit
Number
|
|
Description
|
|
|
|
10.1
|
|
Form of Performance Unit Agreement with the Company’s executive officers under the Company’s Amended and Restated 2002 Long Term Incentive and Stock Award Plan (2016-2018 Long Term Incentive Plan).
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
|
|
|
|
32.1
|
|
Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.2
|
|
Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101
|
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2015, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statement of Stockholders’ Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.
|
|
|
|
|
THE HAIN CELESTIAL GROUP, INC.
|
|
|
By:
|
|
|
Name:
Title:
|
|
PARTICIPANT
|
|
|
|
|
|
Signature
|
|
|
|
|
|
Date
|
•
|
“
Relative Total Shareholder Return
” means the Company’s TSR relative to the TSR of the Peer Companies. Relative Total Shareholder Return will be determined by ranking the Company and the Peer Companies from highest to lowest according to their respective TSRs. After this ranking, the percentile performance of the Company relative to the Peer Companies will be determined as follows:
|
P
= 1 -
|
R
- 1
|
N
- 1
|
•
|
“
TSR
” means, the percentage calculated for each of the Company and each company in the group of Peer Companies by dividing (i) the Closing Average Share Value by (ii) the Opening Average Share Value and subtracting one from the quotient.
|
•
|
“
Opening Average Share Value
” means the average, over the trading days in the Opening Average Period, of the closing price of a company’s stock multiplied by the Accumulated Shares for each trading day during the Opening Average Period.
|
•
|
“
Opening Average Period
” means the 20 trading days immediately following July 1, 2015.
|
•
|
“
Accumulated Shares
” means, for a given trading day, the sum of (i) one (1) share and (ii) a cumulative number of shares of the company’s common stock purchased with dividends declared on a company’s common stock, assuming same day reinvestment of the dividends in the common stock of a company at the closing price on the ex-dividend date, for ex-dividend dates during the Opening Average Period or for the Closing Average Period.
|
•
|
“
Closing Average Share Value
” means the average, over the trading days in the Closing Average Period, of the closing price of a company’s stock multiplied by the Accumulated Shares for each trading day during the Closing Average Period.
|
•
|
“
Closing Average Period
” means the 20 trading days immediately preceding the last day of the Performance Period.
|
•
|
“
Performance Period
” means the period beginning July 1, 2015 and ending on the earlier of June 30, 2018 or the date of a Change in Control.
|
•
|
“
Peer Companies
” shall consist of those companies comprising the S&P Food & Beverage Select Industry Index as of the beginning of the Performance Period.
|
•
|
For purposes of calculating TSR, the value of any
Peer Company shares traded on a foreign exchange will be converted to US dollars using the same exchange rate that the Company uses for financial reporting purposes.
|
•
|
The following example illustrates the calculation of TSR for the Company with a Performance Period of July 1, 2012 to June 30, 2015. For the purposes of the example, the Opening Average Period is 20 trading days immediately following July 1, 2012 and the Closing Average Period is the 20 trading days immediately prior to June 30, 2015.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ Irwin D. Simon
|
Irwin D. Simon
President and Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ Pasquale Conte
|
Pasquale Conte
Executive Vice President and
Chief Financial Officer
|
/s/ Irwin D. Simon
|
Irwin D. Simon
President and Chief Executive Officer
|
/s/ Pasquale Conte
|
Pasquale Conte
Executive Vice President and
Chief Financial Officer
|